Article

Reform Update: Some Question the Value of Value-Based Purchasing

Next year, U.S. healthcare providers will be subject to Medicare penalties if they do not meet up to 26 measures for value-based purchasing.

Next year, U.S. healthcare providers will be subject to Medicare penalties if they do not meet up to 26 measures for value-based purchasing. As physicians wait to see if their payments will be docked or boosted based on how they rank, health policy researchers are continuing to raise questions about how the program works.

The methodology the CMS adopted may lead to distorted comparisons, perverse incentives and may not achieve the desired goals, they warn.

Value-based purchasing is part of the quality incentive program established through the Patient Protection and Affordable Care Act to help drive down costs while promoting high-quality care for Medicare beneficiaries.

Read the full story here: http://bit.ly/1pMGyU3

Source: Modern Healthcare

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Dr Johnie Rose
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health
Dr Andrew S. Oseran
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo